RealTalk MS

Main Content

Photo courtesy of National MS Society

RealTalk MS Is On Right Now!

Join host Jon Strum each week as he breaks down the latest multiple sclerosis news. We’re talking about the amazing MS research that’s taking place in laboratories around the world — and we’re talking to some of the brilliant neuroscientists who are conducting that research!

We’re monitoring the debate among our lawmakers surrounding prescription drug price transparency, healthcare legislation, funding for new and experimental MS research — anything that might impact your MS treatments.

And we’re talking with MS activists, MS caregivers, MS fundraisers, and other heroes who strive to raise the bar for those who battle MS every day.

If you’re affected by multiple sclerosis — as a patient, caregiver, family member, or friend — join us for RealTalk MS.

Episode 456: The First 100 Days Following An MS Diagnosis with Dr. Nancy Sicotte


May 30th is World MS Day! This year, the theme for World MS Day is “My MS Diagnosis,” and I've been thinking about what happens right after that diagnosis. After an individual hears, “You have MS.”

This week, Dr. Nancy Sicotte joins me to discuss the things you should know, the things you should be thinking about, and the things you should be doing in the first 100 days following an MS diagnosis.

Dr. Nancy Sicotte

Dr. Sicotte is the Chair of Neurology and Director of Multiple Sclerosis and Neuroimmunology at Cedars-Sinai in Los Angeles, and she's the past Chair of the National MS Society's National Medical Advisory Committee.

We're also sharing results of a study that showed an exercise hormone protected neurons from inflammatory attack in a mouse model of MS.

And we're sharing encouraging news about an experimental nasal spray that's been shown to delay disability progression and improve fatigue among people with non-active secondary progressive MS.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: World MS Day!  :22

Study reveals an exercise hormone has neuroprotective effects on a mouse model of MS    2:40

Tiziana shares evidence that Foralumab delays progression and improves fatigue in people with non-active secondary progressive MS  4:34

Dr. Nancy Sicotte looks at the first 100 days following an MS diagnosis  8:40

Share this episode  28:51

Next week  29:12

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/456

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com

World MS Day Poster Maker
https://worldmsday.org/poster-maker

STUDY RESULTS: The Exercise Hormone Irisin Has Neuroprotective Effects in a Mouse Model of Multiple Sclerosis
https://www.nature.com/articles/s42255-026-01527-7

CLINICAL TRIAL: A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
https://clinicaltrials.gov/study/NCT06292923

JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 456
Guest: Dr. Nancy Sicotte